Xenetic Biosciences (XBIO) Revenue (2011 - 2026)
Xenetic Biosciences (XBIO) recorded Revenue of $660,601 in Q2 2026, up 12.0% from $589,897 a year earlier but down 18.1% from the prior quarter.
Xenetic Biosciences (XBIO) Revenue (2011 - 2026) Analysis & Trends
On a TTM basis, Xenetic Biosciences' Revenue came in at $3.26 million as of Jun 30, 2026, up 33.3% year-over-year; for FY2025, it came in at $2.98 million, up 19.0% from FY2024.
- Annual Revenue has a five-year compound annual growth rate of 46.8% (FY2020 to FY2025).
- Across earlier years, Revenue came in at $2.5 million in FY2024 (-1.6%), $2.54 million in FY2023 (+48.8%), $1.71 million in FY2022 (+47.1%) and $1.16 million in FY2021 (+165.6%).
- Quarterly Revenue has ranged from $332,604 in Q4 2021 to $1.03 million in Q3 2025 over the past five years.
- On a year-over-year basis, Revenue has increased for four consecutive quarters, with growth averaging 16.0% over the last eight quarters.
- Peak year-over-year performance for Revenue in the last five years was growth of 201.3% in Q3 2021, against a decline of 18.8% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $806,923 (Q1 2026), $766,296 (Q4 2025) and $1.03 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Xenetic Biosciences | 5.44 Mn | -20.39 Mn | - | 660,601.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 660,601.00 |
| Mar 31, 2026 | 806,923.00 |
| Dec 31, 2025 | 766,296.00 |
| Sep 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 589,897.00 |
| Mar 31, 2025 | 593,261.00 |
| Dec 31, 2024 | 648,820.00 |
| Sep 30, 2024 | 614,243.00 |
| Jun 30, 2024 | 726,404.00 |
| Mar 31, 2024 | 510,817.00 |
| Dec 31, 2023 | 671,963.00 |
| Sep 30, 2023 | 611,174.00 |
| Jun 30, 2023 | 651,005.00 |
| Mar 31, 2023 | 605,844.00 |
| Dec 31, 2022 | 486,972.00 |
| Sep 30, 2022 | 414,250.00 |
| Jun 30, 2022 | 416,710.00 |
| Mar 31, 2022 | 388,993.00 |
| Dec 31, 2021 | 332,604.00 |
| Sep 30, 2021 | 349,269.00 |
Xenetic Biosciences Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=XBIO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "XBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=XBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();